To attempt to locate functionally important regions of the interferon (IFN) molecule, recombinant human IFN-a2 was subjected to proteolytic digestion. The bacterial proteinase thermolysin produced two major complementary fragments, and . After reduction with 2-mercaptoethanol and separation of the two major fragments on NaDodSO4/polyacrylamide gel electrophoresis, antiviral activity persisted in the larger, Mr 12,000, fragment consisting of the amino-terminal 110 amino acids.
The availability of large amounts of recombinant DNA-derived interferon (IFN) has fostered investigation of IFN's structure-function relationships; however, the specific structural features required for biologic activity remain largely unknown. Despite disul'ide bond assignment (1), secondary structure measurements (2) , and investigation of novel recombinant IFNs, (3, 4) , little information is available as to which areas of the protein may be functionally important. Modification of the structure of IFNs by using a variety of enzymes and chemicals has yielded varied results. Incubation of IFNs with glycosidic enzymes in general does not appear to alter the antiviral activity (5) . Cleavage of IFNs with endopeptidases such as trypsin or with chemicals such as cyanogen bromide has thus far been unsuccessful in generating active fragments (6, 7) . In contrast, some active species were obtained after treatment with exopeptidases (8) , pepsin (9) , and periodate (10) ; however, reductions in size were modest with the active species of Mr 15,000 or larger. To attempt to identify small functional portions of the IFN molecule we have studied proteolytic fragments of a recombinant human IFN, HuIFN-a2, produced by the bacterial proteinase thermolysin. We report here that proteolysis of this IFN with thermolysin generates a biologically active fragment originating from the amino-terminal end of the molecule.
MATERIALS AND METHODS
Thermolysin was obtained from Calbiochem. HuIFN-a2 (1.5 x 10' units/mg of protein) was the gift of Schering. HuIFNaA (2.0 x 108 units/mg of protein) was the gift of HoffmannLa Roche. 125I-labeled HuIFN-aA (1251-HuIFN-aA) was prepared as described (11) .
Preparative NaDodSO4/polyacrylamide gel electrophoresis (NaDodSO4/PAGE) was performed according to the method of Laemmli (12) . The separating gels were 16% acrylamide/N,N'-methylene bisacrylamide, 0.75 mm in thickness and 12 cm in length. Electrophoresis was performed at 15 mA per slab gel. The gels were stained and destained as described (13) . The stained gel bands were sliced from the gel and eluted as reported (13) . The samples were then assayed for biological activity or dialyzed and lyophilized for amino acid analysis and amino acid sequence determination as described (14) . Continuous elution of IFN fragments was done by the method of Hunkapiller (unpublished data).
IFN antiviral assays were performed by using Madin-Darby bovine kidney (MDBK) cells or human foreskin fibroblasts with vesicular stomatitis virus as reported (15) . Competitive receptor binding assays using 125I-HuIFN-aA and MDBK cells were performed as described (11) .
RESULTS AND DISCUSSION
The effects of thermolysin on the antiviral and receptor binding activities of IFN are shown in Fig. 1 . HuIFN-a2 (0.4 mg/ml) was exposed to thermolysin (0.012 mg/ml) at 370C in 0.1 M Tris HCl buffer with 1 mM CaCl2 at pH 8.0. After 1, 2, and 4 hr, aliquots were removed for antiviral and competitive binding assays. Half of each sample was reduced with 2-mercaptoethanol, and both reduced and unreduced portions were tested for antiviral activity and ability to compete for binding to the IFN receptor. As indicated by the NaDodSO4/ polyacrylamide gel ( Fig. 1 Inset, left portion), digestion over 4 hr resulted in a small reduction of the molecular weight of unreduced IFN. No remaining native IFN band could be identified in the 4-hr digest; calculations based on the minimal amount of IFN visible on gels (0.3 pug) and on the amount of sample applied (8-10 ,sg) indicated that at least 96% of the starting material was cleaved. In spite of this, no change was seen in either the antiviral activity or binding activity ( Fig. 1) . These results are compatible with those of Wetzel et al., who reported that thermolysin cleaves the carboxyl-terminal 13 amino acids without loss of biological activity (6) .
Reduction of thermolysin-digested IFN with 2-mercaptoethanol prior to electrophoresis showed ( Fig. 1 Inset, right portion) that this single major enzymatic product contained two predominant disulfide-linked fragments, which we have designated "A" and "B." Reduced digest was assayed for antiviral and receptor binding affinity. After 4 hr of proteolysis, -'30% of the antiviral activity (0.5 log10 unit) and ==80% of the binding activity of reduced undigested IFN remained. These activities were not due to residual intact IFN because, as noted above, digestion was at least 96% complete. Rather, they reflected biological activity in one or more of the reduced IFN fragments. When the antiviral effects of the reduced fragments were tested with human foreskin fibroblasts as the target cell, only 12% of the activity remained after proteolysis (data not shown). The greater loss in this system is compatible with prior studies indicating that human foreskin fibroblasts may be more sensitive than bovine kidney cells to modifications of the IFN molecule (18) .
To attempt definitive identification of the two fragments, digestion and NaDodSO4/PAGE were performed on a preparative scale. Each of the two major fragments (Fig. 2) 23 (16, 17) .
eluted from the gel, dialyzed, lyophilized, and then subjected to sequence analysis through the first 20 residues using gasphase sequence analysis (14) . Each eluted band contained an apparent single sequence. The larger fragment corresponded to the amino-terminal portion of the intact molecule. The sequence of the smaller fragment began with the leucine at position 111. Thus, the major proteolytic cleavages are between residues 110 to 111 and 153 to 154. Molecular weights for fragments A and B calculated from the amino acid sequence of IFN-a2 are 12,490 and 5,420, respectively.
To determine which fragment showed biologic activity, IFN was digested, reduced with 2-mercaptoethanol, and applied to a NaDodSO4/polyacrylamide gel system allowing continuous elution of material from the bottom of the gel during electrophoresis (unpublished data). Approximately 35 fractions were collected in this way. Aliquots of each fraction were run on gradient analytical gels to determine the presence and molecular weights of eluted fragments, and another portion of each fraction was assayed for antiviral activity. Apparent molecular weights estimated from the mobilities in this system were 9,000-10,000 and 6,000 for the two major fragments. As shown in Fig. 3, activity HuIFN-a2 (4.0 mg/ml) was incubated at 37TC with 0.12 mg of thermolysin per ml (reaction volume, 100 /.d). Under these conditions, -90% digestion required only 30 min of incubation. Aliquots were then reduced with electrophoresis solubilizing buffer containing 3% 2-mercaptoethanol and applied to 16% polyacrylamide gels containing 0.1% NaDodSO4. ' -- (3, 6, 19, 20) . Studies with a monoclonal antibody, which recognizes the last 16 carboxyl-terminal amino acid residues of HuIFN-aA, have confirmed that the carboxyl-terminal region of the HuIFNaA molecule is not involved in interaction with the receptor, for this antibody is capable of binding to HuIFN-aA bound to its receptor (21, 22) . Studies with recombinant DNA-derived HuIFN-aA and HuIFN-aD and their hybrid derivatives have shown that the amino-terminal portion of the HuIFN-as appears to influence the antiviral activity on human cells, whereas their carboxyl-terminal portion appears to influence their activity on mouse cells (3, 23, 24) . Of interest, both the parent and hybrid molecules appear to elicit the antiviral response equally well on bovine kidney cells (3, 23, 24) . Therefore, it appears the bovine receptor for HuIFN-a can accommodate more structural variants than either the human or mouse HuIFN-a receptors and thus may have the ability to recognize multiple sequences or conformations of the HuIFN-as. Our studies are consistent with this proposal, for HuIFN-a- 
